Navigation Links
Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
Date:10/5/2007

DETROIT, Oct. 5 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd., (Amex: CPD) announced today that the US Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Cetirizine Hydrochloride Chewable Tablets, 5 mg and 10 mg (Cetirizine HCl Chewable). Final approval to market this product is anticipated subsequent to the expiry of patent protection on December 25, 2007.

Cetirizine HCl Chewable is indicated for the relief of symptoms associated with seasonal allergic rhinitis due to allergens in adults and children 2 years of age and older; perennial allergic rhinitis in adults and children 6 months of age and older; and for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. This tentative approval is the bioequivalent to Zyrtec Chewable(R), a registered trademark of Pfizer, Inc. Zyrtec Chewable(R) tablets had U.S. sales of approximately $75 million for the 12-month period ended June 30, 2007, according to IMS Data.

Daniel H. Movens, Caraco's Chief Executive Officer, said, "We are extremely pleased to receive this tentative approval and look forward to the expiration date of the patent on December 25, 2007, which will allow Caraco to market the product. We feel that Cetirizine HCl Chewable complements our previously announced FDA tentative approval of Cetirizine Hydrochloride Immediate Release Tablets, 5 mg and 10 mg, and both products will be positive additions to our portfolio by expanding our product offerings."

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic and priva
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. South Africa Wins landmark case against pharmaceutical giants
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Setting up a new pharmaceutical industry in India
5. Medicis Pharmaceutical company enters pediatric market
6. Supply of Radiopharmaceuticals Hampered by Attacks
7. Pharmaceutical companies are targeting patients
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... ThermiHealth today announces the launch ... and Urogynecologists. ThermiVa is a unique temperature controlled ... in aesthetics and other medical specialties. Physicians using ... procedure, and patients reporting excitement about a new ... surgery. ThermiVa was developed by ThermiGyn, a women’s ...
(Date:3/5/2015)... 2015 March is National Nutrition ... sponsored by the Academy of Nutrition and Dietetics. ... Lifestyle," which promotes the consumption of fewer calories, ... and maintaining a healthy weight, reducing risks of ... Whether a person is new to physical fitness ...
(Date:3/5/2015)... March 05, 2015 Elandas announces the ... innovations as the company prepares to announce its next ... of individuals in the Life Sciences field. , “Elandas ... clients,” said Elandas CEO Ryan Roberts. “We have been ... organization through our collaborative efforts. As we continue to ...
(Date:3/4/2015)... (PRWEB) March 05, 2015 Understanding China’s ... — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/UnderstandingChinaMDRegs ... and revamped regulations for medical devices in China. ... medical devices — research and development, approval, manufacturing, distribution, ... — those currently in development as well as those ...
(Date:3/4/2015)... In the Ultimate Fighting Championship, each event ... main event. For UFC 189 , just one official ... the UFC Featherweight Championship. Brazilian champion Jose “Junior” Aldo will ... Ireland, Conor “Notorious” McGregor. UFC 189 will take place on ... Vegas, NV. , When it comes to the featherweight division ...
Breaking Medicine News(10 mins):Health News:ThermiHealth Announces the Introduction of ThermiVa in North America to OB-GYNs 2Health News:ThermiHealth Announces the Introduction of ThermiVa in North America to OB-GYNs 3Health News:National Nutrition Month® Tips for Athletes from the Austin Sports Medicine Team at Medicine in Motion 2Health News:National Nutrition Month® Tips for Athletes from the Austin Sports Medicine Team at Medicine in Motion 3Health News:Elandas Creates Advisory Board to Help Guide Innovation 2Health News:FDAnews Announces: Understanding China’s New Medical Device Regulations Webinar, March 26, 2015 2Health News:FDAnews Announces: Understanding China’s New Medical Device Regulations Webinar, March 26, 2015 3Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 2Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 3
... projected by the U.S. Census Bureau that by the year 2030, ... million in the U.S. alone, and more than one billion worldwide. ... at least one disorder of the pelvic floor in her lifetime. ... up with practitioners across the state to create the Rhode Island ...
... to loud workplace noise may affect quality of sleep in ... by Ben-Gurion University of the Negev researchers. ... the sleep quality of individuals at the same workplace, some ... Workers with hearing loss had a higher average age ...
... Jenifer Goodwin HealthDay Reporter , MONDAY, Jan. 24 ... years old become the healthiest, wealthiest and most successful adults, ... at age 3 are more likely to drop out of ... concluded. Researchers analyzed data on about 1,000 children ...
... January 2011) -- The MSD Wellcome Trust Hilleman Laboratories ... a feasibility study into how new technologies might be ... developing country needs in mind. Formulations based on ... their potential to improve product stability, ease of use, ...
... MONDAY, Jan. 24 (HealthDay News) -- For many people, ... strong as they think. In fact, spouses sometimes ... a new study suggests. "People commonly believe ... strangers. That closeness can lead people to overestimate how ...
... Genetics in Medicine , the official journal of the ... paper by Tufts University faculty calling for a moderate, ... school curricula. For 16 months, a multi-disciplinary ... education regarding personalized genomic testing at Tufts University School ...
Cached Medicine News:Health News:Women & Infants launches Rhode Island Network for Pelvic Floor Disorders 2Health News:Self-Control Could Turn Kids Into Successful Adults 2Health News:Self-Control Could Turn Kids Into Successful Adults 3Health News:MSD Wellcome Trust Hilleman Laboratories announces first project 2Health News:Close Relationships Sometimes Mask Poor Communication 2Health News:Tufts University calls for moderate approach to teaching personalized genomic testing 2
(Date:3/4/2015)... 4, 2015 The March 3, 2015, order from the ... change their products, labels to clarify the drugs, intended use ... stroke is necessary to protect the public from injury from ... at Simmons Hanly Conroy . The order ... the products – currently taken by millions of U.S. men ...
(Date:3/4/2015)... Texas , March 4, 2015 ... II pilot study in patients with moderate to ... Dermatology. The open-label Phase II trial evaluated the ... monoclonal antibody that targets interleukin-1 alpha (IL-1a). IL-1a ... inflammatory cells present in skin lesions. The Company ...
(Date:3/4/2015)...   Mayo Clinic and Gentag, Inc ... generation of wearable biosensors designed to fight obesity and ... will be game-changer. These patch biosensors may help us ... M.D., Ph.D. , a Mayo Clinic endocrinologist ... be integrated into the care people receive." ...
Breaking Medicine Technology:Simmons Hanly Conroy, LLC: FDA Orders Label Warnings on Testosterone Drugs Concerning Normal Aging Use and Heart Attack-Stroke Risks 2XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3
... 5, 2011 The national Tourette Syndrome Association, Inc., ... 10 Rockefeller Plaza, created to generate awareness and acceptance ... disorder, Tourette Syndrome. "We Have Tourette,s But ... directly from those who struggle everyday with the symptoms ...
...   Ansell Limited (ANN.AX), a ... Sandel Medical,Industries, LLC, a recognized leader in the development ... The Company has,turnover of US$10m p.a. Ansell will continue ... name. The Sandel product range covers six ...
Cached Medicine Technology:EHE International Showcases The National Tourette Syndrome Association, Inc. with Month-Long Window Display in Rockefeller Center Plaza 2Ansell Limited Acquires Sandel Medical Industries LLC, an Innovator in Surgical Safety Solutions 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: